MT-III, a snake venom GIIA sPLA 2 , which shares structural and functional features with mammalian GIIA sPLA 2 s, activates macrophage defense functions including lipid droplet (LDs) formation, organelle involved in both lipid metabolism and inflammatory processes. Macrophages (MΦs) loaded with LDs, termed foam cells, characterize early blood vessel fatty-streak lesions during atherosclerosis. However, the factors involved in foam cell formation induced by a GIIA sPLA 2 are still unknown. Here, we investigated the participation of lipid homeostasis-related factors in LD formation induced by MT-III in macrophages. We found that MT-III activated PPAR-γ and PPAR-β/δ and increased the protein levels of both transcription factors and CD36 in macrophages. Pharmacological interventions evidenced that PPAR-γ, PPAR-β/δ, and CD36 as well as the endoplasmic reticulum enzymes ACAT and DGAT are essential for LD formation. Moreover, PPAR-β/δ, but not PPAR-γ, is involved in MT-III-induced PLIN2 protein expression, and both PPAR-β/δ and PPAR-γ upregulated CD36 protein expression, which contributes to MT-III-induced COX-2 expression. Furthermore, production of 15-d-PGJ 2 , an activator of PPARs, induced by MT-III, was dependent on COX-1 being LDs an important platform for generation of this mediator.
Introduction
Secreted PLA 2 (sPLA 2 ) enzymes comprise the largest family of PLA 2 s and comprise 12 isoforms subdivided in structural collections I/II/V/X and two other atypical structural collections (III and XII) [1, 2] . sPLA 2 -IIA is often referred as the inflammatory sPLA 2 , but the molecular mechanism underlying its proinflammatory action is not fully understood. These enzymes are able to release fatty acids from cell membranes, leading to subsequent production of lipid mediators. Distinct and unique roles of these enzymes in diverse biological events, including digestion, host defense, reproduction, and development of inflammatory diseases and metabolic disorders, have been described [2] . sPLA 2 s are major protein components of Bothrops snake venoms and are classified into groups I and II, according to their biochemical and structural characteristics. Noteworthy, sPLA 2 s from Bothrops snake venoms share structural and functional features with mammalian inflammatory GIIA sPLA 2 s, which are found in high concentrations in inflammatory exudates [3, 4] . Our group has previously demonstrated that an Asp49 sPLA 2 , named myotoxin-III (MT-III), isolated from Bothrops asper snake venom, activates inflammatory functions of macrophages, including formation of lipid droplets (LDs) and upregulation of perilipin 2 (PLIN2), a scaffold protein involved in LD assembly and macrophage differentiation into foam cells [5] [6] [7] . However, the mechanisms involved in foam cell formation induced by sPLA 2 MT-III are still unclear.
LDs are cytoplasmic organelles, present in high levels in foam cells, that are comprised by a hydrophobic core of neutral lipids (triglycerides and cholesterol esters) surrounded by a phospholipid monolayer and a growing list of associated proteins [7] [8] [9] . LDs are found in inflammatory leukocytes and described as rich deposits of esterified arachidonic acid (AA), a precursor of eicosanoids, and enzymes necessary for their synthesis, including cyclooxygenases (COX) and prostaglandin E 2 synthase [10] . The biogenesis of LDs is a tightly regulated process in which lipid homeostasis-related transcription factors, such as peroxisome proliferatoractivated receptors (PPARs), play a key role. Activated PPARs upregulate the uptake of free fatty acids by increasing the expression of the fatty acid transporter CD36 [11, 12] and LD formation through increased expression of LD-associated proteins, such as PLIN2. Upregulation of PPAR-γ and PPAR-β/δ has been shown in foam macrophages [13] , and deletion of these transcription factors resulted in a decreased number of LDs in cells stimulated with pathogens or free fatty acids. However, the implication of these factors in foam cell formation induced by group IIA secreted PLA 2 s remains unknown. In addition, the endoplasmic reticulum (ER) enzymes acyl-CoA:cholesterol acyltransferase (ACAT) and diacylglycerol O-acyltransferase (DGAT), responsible for the synthesis of cholesterol (ChE) and triacylglycerol (TG), respectively, have also been associated with foam cell formation in diverse pathological and inflammatory conditions [14] . Due to the tight association between an unbalanced lipid homeostasis and foam cell formation seen in diverse inflammatory conditions, we investigated the participation of distinct lipid homeostasis-related factors, such as the transcription factors PPAR-γ and PPAR-β/δ, the ER enzymes DGAT and ACAT, and CD36 scavenger receptor in LD formation induced by the snake venom GIIA sPLA 2 , MT-III, in macrophages.
Materials and Methods

Chemicals and Reagents.
Heparin was obtained from Roche Quimicos Farmaceuticos S.A. (Rio de Janeiro, S.A., Brazil) and Hema-3 stain from Biochemical Sciences (Swedesboro, NJ, USA). MTT and L-glutamine were obtained from USB Thermo Fisher Scientific (Cleveland, OH, USA). GW9662, GSK0660, and A922500 were purchased from Merck KGaA (Darmstadt, HE, Germany). TMP-153 and 15-d-PGJ2 antibody were obtained from Cayman Chemical (Ann Arbor, MI, USA). PPAR-γ and PPAR-β/δ antibodies were purchased from Santa Cruz Biotechnology (Dallas, TX, USA). CD36 antibody was obtained from R&D Systems (Minneapolis, MN, EUA). 15-deoxy-Δ 12,14 -PGJ2 ELISA kit was purchased from Enzo Life Sciences (Farmingdale, NY, USA). E-toxate LAL kit, mouse mAb anti-β-actin, EDAC, sulfo-N-succinimidyl oleate (SSO), and Nile Red were purchased from Sigma-Aldrich (St. Louis, MO, USA). Secondary antibodies, anti-mouse and anti-guinea pig, conjugated to HRP and nitrocellulose membrane, were obtained from GE Healthcare (Buckinghamshire, UK). Gentamicin was purchased from Schering-Plough (Whitehouse Station, NJ, USA). DMSO and BSA were obtained from Amresco (Solon, OH, USA). RPMI 1640, thiocarbohydrazide, and OsO 4 were purchased from Sigma-Aldrich (St. Louis, MO, USA). PLIN2 antibody, AlexaFluor 488 antibody, and iodide propidium were purchased from Thermo Fisher Scientific (Sao Paulo, S.P., Brazil). GA, TG, and all salts used were obtained from Merck (Darmstadt, Germany). PFA was purchased from Electron Microscopy Sciences (Hatfield, PA, USA). Fluoromont G was purchased from Molecular Probes (Eugene, OR, USA). Donkey serum was obtained from Jackson ImmunoResearch Laboratories (West Grove, PA, USA). Triton-X was obtained from Union Carbide (Houston, TX, USA). (18-20 g ) were obtained from Butantan Institute (São Paulo, Brazil). Animals were housed in a temperature-controlled room (22-24°C) with a 12 h light-dark cycle and fresh water and food ad libitum. This study was approved by the Butantan Institute Animal Experimentation Ethics Committee (reference number 760/10) in accordance with the procedures laid down by the Universities Federation for Animal Welfare.
Animals. Male Swiss mice
Phospholipase A 2 (MT-III). MT-III was isolated from
Bothrops asper venom by ion-exchange chromatography on CM-Sephadex C-25 using the conditions described by Gutierrez and Lomonte [15] (verificar referência), followed by RP-HPLC on a C8 semipreparative column (10 × 250 mm; Vydac) eluted at 2.0 mL/min with a 0-70% acetonitrile gradient containing 0.1% (v/v) trifluoroacetic acid, during 30 min, on an Agilent 1200 instrument monitored at 215 nm. Homogeneity of the final preparation was assessed by analytical RP-HPLC on a C4 column (4.6 × 150 mm) using a 0-60% acetonitrile gradient. The absence of endotoxin contamination in the MT-III preparation was demonstrated by the quantitative Limulus amebocyte lysate (LAL) test [16] , which revealed undetectable levels of endotoxin (<0.125 EU/mL).
Harvesting of Macrophages.
Peritoneal macrophages were harvested from mice 4 days after i.p. injection of 1 mL of 3% thioglycolate. Animals were killed under CO 2 atmosphere, and cells were harvested by washing peritoneal cavities with 3 mL of PBS, pH 7.2, containing 10 IU/ mL heparin. Aliquots of the washes were used for total cell counts in a Neubauer chamber after dilution (1 : 20, v/v) in Turk solution (0.2% crystal violet dye in 30% acetic acid). To verify the predominance of macrophages in samples, differential cell counts were performed on smears stained with Hema3. More than 95% of the cell population consisted of macrophages, as determined by conventional morphological criteria. The remaining wash volumes were centrifuged at 500 ×g for 6 min (4°C), and the cell pellets were used for subsequent studies after suitable dilutions.
Stimulation and Treatment of Macrophages.
Macrophages were seeded on glass coverslips at a density of 2 × 10 5 cells/coverslip and allowed to attach for 30 min at 37°C under a 5% CO 2 atmosphere. Nonadherent cells were removed by washing with PBS. Cell monolayers were cultured for 1 h in RPMI-1640 supplemented with 40 μg/mL gentamicin sulfate and 2 mM L-glutamine at 37°C and 5% CO 2 and were then challenged with MT-III (0.4 μM) or medium (control). This concentration of MT-III was selected on the basis of the previous studies, since it induces the formation of LDs in macrophages (Leiguez et al., [17] ). Where appropriate, the following inhibitors were used: GW9662 (10 μM), inhibitor of PPAR-γ; GSK0660 (10 μM), inhibitor of PPAR-β/δ; SS0 (25 μM), inhibitor of CD36; A922500 (100 nM), inhibitor of DGAT enzyme; and TMP-153 (100 nM), inhibitor of ACAT enzyme. All stock solutions were prepared in DMSO and stored at −20°C. Aliquots were diluted in RPMI-1640 to the required concentration immediately before use. The final DMSO concentration was always lower than 1% and had no effect on lipid body numbers. All pharmacological inhibitors were added between 30 and 60 min before stimulation of macrophages with MT-III or medium (control). Cells treated with the inhibitors were analyzed for viability by the tetrazolium-based (MTT) colorimetric assay. No significant changes in cell viability were registered with any of the above agents or vehicle at the concentrations used (data not shown). O, and then dried and mounted. The morphology of the fixed cells was observed, and round osmiophilic structures were identified as lipid droplets, which were then counted under phase-contrast microscopy using the 100x objective lens in 50 consecutively scanned leukocytes in each coverslip. For assays with fluorescent-labeled lipid droplets, macrophages (2 × 10 5 cells) that adhered to glass coverslips were incubated with Nile Red staining solution freshly prepared in 0.1 M phosphate buffer (10 μg/mL) for 20 min at room temperature and washed with phosphate buffer. After several washes, the coverslips were mounted with fluoromont G and examined under a fluorescence microscope equipped with the appropriate filter (Zeiss LSM 510 Meta, Dublin, CA, USA).
2.7. Western Blotting. Aliquots of MT-III-stimulated and nonstimulated cells (2 × 106 cells) were lysed with 100 μL of sample buffer (0.5 M Tris-HCl, pH 6.8, 20% SDS, 1% glycerol, 1 M β-mercaptoethanol, and 0.1% bromophenol blue) and boiled for 10 min. Samples were resolved by SDS polyacrylamide gel electrophoresis (SDS-PAGE) on 10% bisacrylamide gels overlaid with a 5% stacking gel. Proteins were then transferred to nitrocellulose membrane (GE Healthcare, Buckinghamshire, UK) using a Mini Trans-Blot® (Bio-Rad Laboratories, Richmond, CA, USA). The membranes were blocked for 1 h with 5% nonfat dry milk in TTBS (20 mM Tris, 100 mM NaCl, and 0.5% Tween 20) and incubated with primary antibodies against PLIN2 (1 : 2000 dilution) or PPAR-γ or PPAR-β/δ or CD36 (1 : 2000) and β-actin (1 : 3000) for 1 h. They were then washed and incubated with the appropriate secondary antibody conjugated to horseradish peroxidase. Detection was made by the enhanced chemiluminescence (ECL) method according to the manufacturer's instructions (GE Healthcare, Buckinghamshire, UK). Band densities were quantified with a GS-800 Densitometer (BioRad Laboratories, Richmond, CA) using the image analysis software from Molecular Analyst® (Bio-Rad Laboratories, Richmond, CA). 2 Quantification. Release of 15-d-PGJ 2 was determined by enzyme immunoassay using commercial kits. In brief, 50 μL aliquots of each sample were incubated with the eicosanoids conjugated with acetylcholinesterase and the specific rabbit antiserum in 96-well plates were coated with anti-rabbit IgG mouse monoclonal antibody. After addition of the substrate, the absorbance of the samples was recorded at 405 nm in a microplate reader (Labsystems Multiskan), and concentrations of 15-d-PGJ 2 were estimated from standard curves. 2.11. Statistical Analysis. Data are expressed as the mean ± standard error of mean (SEM) of at least three independent experiments. Multiple comparisons among groups were performed by one-way analysis of variance (ANOVA) followed by Tukey's test. Values of probability lower than 5% (p < 0.05) were considered significant.
15-d-PGJ
Results
PPAR-γ and PPAR-β/δ Contribute to LD Formation, but
Only PPAR-β/δ Is Involved in Increase of PLIN2 Protein Expression in Macrophages Stimulated by MT-III. Participation of PPAR-γ and PPAR-β/δ in the signaling triggered by fatty acids has been previously reported [19] . Therefore, the involvement of these factors in MT-III-induced LD biogenesis was investigated using pharmacological approaches. The effects of selected pharmacological treatments were evaluated 12 h after incubation of macrophages with MT-III. As seen in Figure 1(a) , pretreatment of cells with GW9662 (10 μM), a PPAR-γ antagonist, caused 74% reduction in the number of LDs in MT-III-stimulated macrophages when compared with vehicle-treated macrophages stimulated with MT-III. However, pretreatment of cells with the PPAR-β/δ antagonist, GSK0660 abolished LD formation induced by MT-III in macrophages when compared with vehicle-treated macrophages stimulated with MT-III. In an attempt to better understand the involvement of PPAR-γ and PPAR-β/δ in MT-III-induced LD formation, we further evaluated the contribution of these transcription factors in PLIN2 protein expression induced by MT-III. PLIN2 is a structural protein implicated in LD assembly [5, 6] and transcriptionally controlled by factors involved in lipid homeostasis, including PPARs [11] . Figure 1(b) shows that PLIN2 protein expression was abolished in cells pretreated with the antagonist of PPAR-β/δ GSK0660 and then stimulated with MT-III. However, the treatment of cells with GW9662 followed by incubation with MT-III did not alter PLIN2 protein expression induced by this sPLA 2 . Altogether, these data indicate that both PPAR-γ and PPAR-β/δ are involved in LD formation stimulated by MT-III in macrophages while only PPAR-β/δ acts by increasing PLIN2 protein expression.
MT-III Upregulates PPAR-γ and PPAR-β/δ Protein Expression in Macrophages.
As an additional mechanism involved in lipid accumulation induced by MT-III in peritoneal macrophages, we investigated the ability of MT-III to upregulate PPAR-γ and PPAR-β/δ protein expression. Levels of PPAR-γ and PPAR-β/δ protein expression were analyzed by Western blot in cells stimulated with MT-III or RPMI (control) for selected time intervals (1-24 h). As seen in Figure 2 (a), levels of PPAR-γ protein expression were increased in macrophages stimulated by MT-III in all time windows evaluated (1-24 h) when compared with the corresponding controls. Similarly, Figure 2 (b) shows that MT-III increased PPAR-β/δ protein expression in macrophages from 1 up to 24 h, compared to control cells. Taken together, these data demonstrate the capacity of MT-III to induce PPARγ and PPAR-β/δ protein expression in peritoneal macrophages.
MT-III Induces 15-d-PGJ 2 Production via COX-1
Pathway and Activates PPAR-γ and PPAR-β/δ. It is known that lipid mediators, mainly 15-d-PGJ 2 , are potent endogenous activators of PPAR family [20, 21] . We then evaluated the ability of MT-III to induce 15-d-PGJ 2 production in peritoneal macrophages. 15-d-PGJ 2 levels were measured in (Figure 3(b) ). Therefore, 15-d-PGJ 2 production is dependent on COX-1, but not COX-2 pathway in macrophages stimulated by MT-III.
To confirm the activation of these factors by MT-III, an immunofluorescence assay was performed to evaluate translocation of PPAR-γ and PPAR-β/δ into the nucleus of macrophages. As illustrated in Figure 3 (c), macrophages stimulated with RPMI (control) for 3 or 12 h exhibited a fluorescent staining (green) for PPAR-γ, which did not colocalize to nucleus staining (red). In macrophages stimulated with MT-III (0.4 μM) for 3 h, fluorescent labeling for PPAR-γ was seen colocalized in the nucleus, indicating translocation of this factor to the nuclear region. Figure 3 [10] . Considering the increased levels of 15-d-PGJ 2 in MT-III-stimulated macrophages, we hypothesize that LDs could constitute a relevant site for production of 15-d-PGJ 2 . In order to investigate this hypothesis, macrophages stimulated with MT-III or RPMI (control) were incubated with EDAC to immobilize the newly synthesized eicosanoids [18] and immunostained with antibodies against 15-d-PGJ 2 . LDs were stained with Nile Red. As illustrated in PPARs triggers an increase in enzymatic activity of enzymes involved in neutral lipid synthesis [22] . DGAT and ACAT are the main enzymes responsible for the synthesis of triacylglycerol (TAG) and cholesterol (CE), respectively, both present in LD core [23, 24] . Our results show that pretreatment of cells with A922500, a DGAT inhibitor, or TMP-153, an ACAT inhibitor, abolished LD formation induced by MT-III when compared with vehicle-treated cells stimulated with MT-III ( Figure 5(a) ). As shown in Figures 5(b) and 5(c), incubation of macrophages with MT-III induced a significant increase in levels of TAG and CE, respectively, between 1 and 6 h in comparison with respective control cells. These results indicate the involvement of DGAT and ACAT in MT-III-induced LD formation and the composition of these lipid organelles.
CD36 Contributes to LD Formation and COX-2 Protein
Expression Induced by MT-III. Macrophages internalize lipids by different scavenger receptors, among which is CD36. This receptor binds oxidized phospholipids/lipoproteins and long-chain fatty acids, leading to LD formation and, as a consequence, to differentiation of macrophages to foam cells during atherosclerotic processes [25, 26] . To verify the role of CD36 in LD formation induced by MT-III, we evaluated the effect of sulfosuccinimidyl oleate compound (SSO), a CD36 antagonist, on MT-III-induced LD formation. As shown in Figure 6 
Discussion
Lipid accumulation in monocytes and macrophages is responsible for differentiation of these cells into foam cells and represents a key step in the development of atherosclerosis [5, 28] . Therefore, these cells have been used as targets to understand the inductors and mechanisms involved in atherosclerotic process. Hereby, we demonstrated the activation, expression, and contribution of different factors involved in lipid accumulation induced by MT-III, a group IIA sPLA 2 , in phagocytic cells. Our results indicate that MT-III is able to induce activation of PPAR-γ and PPAR-β/δ in macrophages, since both transcription factors were translocated into nucleus in cells stimulated by this sPLA 2 . In the present experimental conditions, translocation of PPAR-β/δ into the nucleus was higher than that of PPAR-γ and showed a longterm profile. Considering that PPARs are activated by lipid mediators and free fatty acids [29] and that arachidonic acid (AA) was shown to activate PPAR-γ in alveolar macrophages [30] , the ability of MT-III to induce release of AA and other polyunsatured fatty acids from macrophage membranes [17, 31] may provide a favorable environment for activation of these factors. Although, activation of PPAR-γ and PPAR-β/δ by LDL modified by a sPLA 2 from Naja mossambica snake venom has been reported in the literature [32] ; to our knowledge, this is the first demonstration that a group IIA sPLA 2 per se induces activation of PPAR-γ and PPAR-β/δ. The involvement of PPAR-γ and PPAR-β/δ in LD formation and regulation of expression of PLIN2, a protein involved in the uptake of fatty acids and differentiation of macrophages into foam cells, have been demonstrated in the literature [33] [34] [35] . Our findings that inhibition of PPAR-β/δ abolished both LD formation and PLIN2 protein expression induced by MT-III indicate that PPAR-β/δ by regulating PLIN2 expression plays a crucial role in LD formation induced by the studied sPLA 2 . On the other hand, while inhibition of PPAR-γ activation reduced LD formation, no modification of PLIN2 protein expression was observed, evidencing that upon stimulus by MT-III, PPAR-γ and PPAR-β/δ regulate LB formation by targeting different genes related to lipid uptake. This result contrasts with those demonstrating that PPAR-γ regulates PLIN2 protein expression induced by oxidized low-density lipoprotein or troglitazone, a PPAR-γ agonist [36, 37] . Furthermore, the data here obtained shows that MT-III is able to upregulate PPAR-γ and PPAR-β/δ protein expression, underscoring an additional mechanism by which this group IIA sPLA 2 induces LD formation. In addition, our present results showed a marked and early production of 15-d-PGJ 2, which is dependent on COX-1, but not COX-2 pathway. These findings are in line with previous results showing that MT-III induces an early increase of COX-1 activation in macrophages [31] . On the other hand, upregulation of COX-2 protein expression observed in macrophages stimulated by MT-III may be related to biosynthesis of proinflammatory prostaglandins, which were not investigated in the present study, since inhibition of COX-2 did not affect MT-III-induced release of 15-d-PGJ 2 . This resolutive mediator is recognized as a relevant activator of PPAR family and has been found in macrophages of atherosclerotic lesions [38] . Therefore, the tight correlation between the profiles of 15-d-PGJ 2 [38] . Additionally, our findings reinforce the idea that LDs can also be implicated in the negative regulation of inflammatory response, as 15-d-PGJ 2 is a recognized preresolving mediator, signaling the switch from acute inflammatory phase to the resolving phase of inflammation [43, 44] . Hence, the formation of this mediator upon the action of MT-III may reflect a regulatory mechanism to dampen the inflammatory reaction elicited by the enzyme. In addition, our present results demonstrate that LD formation induced by MT-III is largely dependent on the endoplasmic reticulum enzymes DGAT and ACAT, since inhibitors of their enzymatic activities abolished LD formation induced by MT-III. Moreover, the increased levels of TAG and CE detected under MT-III stimulation give support to the participation of DGAT and ACAT in LD formation induced by this sPLA 2 . Our data are in agreement with findings that DGAT and ACAT are involved in LD formation in a number of inflammatory conditions [45] [46] [47] . PPAR-γ agonists have been described to induce expression of DGAT and the consequent increase of triacylglycerol storages [48] . However, gene expression of DGAT and ACAT was not induced by MT-III in the present experimental condition (data not shown)
Another PPAR-regulated factor relevant for LD formation in macrophages during atherogenic processes is the receptor CD36 [49] . Our results demonstrating that inhibition of CD36 markedly reduced LD formation imply the involvement of this scavenger receptor in foam cell formation induced by MT-III in macrophages. In support of this finding, upregulation of CD36 protein expression by this sPLA 2 was observed. Moreover, our data showed that the increased expression of this receptor induced by MT-III is regulated by PPAR-β/δ and PPAR-γ, since inhibition of these transcription factors abolished CD36 protein expression. It is known that activation of the CD36 receptor triggers a signaling pathway that leads to the synthesis of inflammatory lipid mediators [27, 50] . Furthermore, the observation that inhibition of CD36 downregulated COX-2 protein expression suggests a role for this receptor in the formation of prostanoids in the late periods of activation of macrophages induced by MT-III. Altogether, these findings emphasize the crucial role of PPAR-β/δ and PPAR-γ for lipid accumulation in macrophages stimulated by group IIA-sPLA 2 .
In conclusion, our data highlight the mechanisms involved in LD formation induced by MT-III, a secreted phospholipase A 2 from snake venom (Figure 8 ). MT-III was able to increase the expression of the transcription factors PPAR-γ, PPAR-β/δ, and of the scavenger receptor CD36 in peritoneal macrophages. Also, MT-III activated these nuclear transcription factors. Inhibition of these 
Additional Points
Summary Statement. Lipid droplet formation induced by a snake venom GIIA sPLA 2 in macrophages depends on lipid metabolism factors mainly PPAR-γ and PPAR-β/δ, providing new insights into mechanisms of macrophage foam cell formation.
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